-
Pennant Reports Second Quarter 2024 Results
المصدر: Nasdaq GlobeNewswire / 06 أغسطس 2024 16:05:01 America/New_York
EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the second quarter of 2024, reporting GAAP diluted earnings per share of $0.18 for the second quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.24 for the quarter (1).
Second Quarter Highlights
- Total revenue for the second quarter was $168.7 million, an increase of $36.5 million or 27.6% over the prior year quarter;
- Net income for the second quarter was $5.7 million, an increase of $2.9 million or 103.4% over the prior year quarter;
- Adjusted net income for the second quarter was $7.3 million, an increase of $1.9 million or 35.0% over the prior year quarter;
- Segment Adjusted EBITDAR from Operations for the second quarter was $23.5 million, an increase of $4.0 million or 20.5% over the prior year quarter;
- Adjusted EBITDA for the second quarter was $13.2 million, an increase of $3.1 million or 30.6% over the prior year quarter;
- Home Health and Hospice Services segment revenue for the second quarter was $125.3 million, an increase of $30.3 million or 31.9% over the prior year quarter;
- Home Health and Hospice Services segment adjusted EBITDAR from operations for the second quarter was $21.2 million, an increase of $5.5 million or 35.3% over the prior year quarter; and segment adjusted EBITDA from operations the second quarter was $19.6 million, an increase of $5.2 million or 36.3% over the prior year quarter;
- Total home health admissions for the second quarter were 14,140, an increase of 3,699 or 35.4% over the prior year quarter; total Medicare home health admissions for the second quarter were 5,738, an increase of 889 or 18.3% over the prior year quarter;
- Hospice average daily census for the second quarter was 3,220, an increase of 726 or 29.1% compared to the prior year quarter;
- Senior Living Services segment revenue for the second quarter was $43.4 million, an increase of $6.2 million or 16.6% over the prior year quarter; average occupancy for the second quarter was 78.8%, an increase of 80 basis points over the prior year quarter, and average monthly revenue per occupied room for the second quarter was $4,790 an increase of $378 or 8.6% over the prior year quarter;
- Senior Living segment adjusted EBITDAR from operations for the second quarter was $12.8 million, an increase of $1.1 million or 9.6% over the prior year quarter; and segment adjusted EBITDA from Operations for the second quarter was $4.1 million, an increase of $0.5 million or 14.8% over the prior year quarter.
(1) See "Reconciliation of GAAP to Non-GAAP Financial Information.” Operating Results
“We are pleased to report excellent second quarter results, which reflect strong performance in our mature operations, coupled with robust acquisition activity,” said Brent Guerisoli, Pennant’s Chief Executive Officer. “Our on-going investment in leadership has positioned us well to add value to our existing operations even as we acquire new ones. With our solid operating results and healthy balance sheet, we are excited for continued success in the second half of the year. We are updating our annual guidance based on the sustainable momentum we see in the business, and the accretive additions that will contribute to the bottom line through the remainder of 2024.”
A discussion of the Company's use of Non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR and adjusted EBITDA, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three and six months ended June 30, 2024, which has been filed with the SEC today and can be viewed on the Company’s website at www.pennantgroup.com.
2024 Guidance
Management is updating its annual guidance as follows: total revenue is anticipated to be between $654.0 million and $694.5 million; full year 2024 adjusted earnings per diluted share is anticipated to be between $0.89 and $0.95; and full year 2024 adjusted EBITDA is anticipated to be between $50.7 million and $53.8 million.
“The Company’s updated guidance incorporates current operations and organic growth, diluted weighted average shares outstanding of approximately 30.7 million, and a 25.8% effective tax rate,” stated Lynette Walbom, Pennant’s Chief Financial Officer. “It anticipates continued strong operating performance through the end of the year, hospice reimbursement rate adjustments, increased interest expense, and the contributions from our joint ventures and management agreements. It excludes unannounced acquisitions, the announced purchase of Signature’s Oregon assets, start-ups, share-based compensation, acquisition-related costs, or one-time implementation and unusual items.”
Conference Call
A live webcast will be held tomorrow, August 7, 2024 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s second quarter 2024 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.
About Pennant
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 117 home health and hospice agencies and 54 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.
These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.
Contact Information
Investor Relations
The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.comSOURCE: The Pennant Group, Inc.
THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited, in thousands, except for per-share amounts)Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenue $ 168,745 $ 132,281 $ 325,660 $ 258,745 Expense Cost of services 135,313 106,176 261,308 208,778 Rent—cost of services 10,524 9,836 20,908 19,433 General and administrative expense 11,878 8,791 23,314 17,496 Depreciation and amortization 1,468 1,214 2,799 2,494 Loss (gain) on disposition of property and equipment, net — 3 (755 ) 3 Total expenses 159,183 126,020 307,574 248,204 Income from operations 9,562 6,261 18,086 10,541 Other (expense) income, net: Other (expense) income (2 ) 35 83 65 Interest expense, net (1,622 ) (1,453 ) (3,414 ) (2,859 ) Other expense, net (1,624 ) (1,418 ) (3,331 ) (2,794 ) Income before provision for income taxes 7,938 4,843 14,755 7,747 Provision for income taxes 1,844 1,921 3,603 2,828 Net income 6,094 2,922 11,152 4,919 Less: Net income attributable to noncontrolling interest 404 125 556 272 Net income attributable to The Pennant Group, Inc. $ 5,690 $ 2,797 $ 10,596 $ 4,647 Earnings per share: Basic $ 0.19 $ 0.09 $ 0.35 $ 0.16 Diluted $ 0.18 $ 0.09 $ 0.35 $ 0.15 Weighted average common shares outstanding: Basic 30,142 29,809 30,094 29,780 Diluted 30,781 30,193 30,583 30,171 THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)June 30, 2024 December 31, 2023 Assets Current assets: Cash $ 3,043 $ 6,059 Accounts receivable—less allowance for doubtful accounts of $253 and $259, respectively 76,089 61,116 Prepaid expenses and other current assets 14,981 12,902 Total current assets 94,113 80,077 Property and equipment, net 40,905 28,598 Right-of-use assets 267,353 262,923 Deferred tax assets, net 114 — Restricted and other assets 11,953 9,337 Goodwill 110,487 91,014 Other indefinite-lived intangibles 77,542 67,742 Total assets $ 602,467 $ 539,691 Liabilities and equity Current liabilities: Accounts payable $ 15,392 $ 10,841 Accrued wages and related liabilities 30,601 28,256 Operating lease liabilities—current 18,473 17,122 Other accrued liabilities 19,223 15,330 Total current liabilities 83,689 71,549 Long-term operating lease liabilities—less current portion 251,613 248,596 Deferred tax liabilities, net 1,336 1,855 Other long-term liabilities 10,662 8,262 Long-term debt, net 82,174 63,914 Total liabilities 429,474 394,176 Commitments and contingencies Equity: Common stock, $0.001 par value; 100,000 shares authorized; 30,493 and 30,150 shares issued and outstanding, respectively, at June 30, 2024; and 30,297 and 29,948 shares issued and outstanding, respectively, at December 31, 2023 30 29 Additional paid-in capital 110,311 105,712 Retained earnings 45,259 34,663 Treasury stock, at cost, 3 shares at June 30, 2024 and December 31, 2023 (65 ) (65 ) Total The Pennant Group, Inc. stockholders’ equity 155,535 140,339 Noncontrolling interest 17,458 5,176 Total equity 172,993 145,515 Total liabilities and equity $ 602,467 $ 539,691 THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented: Six Months Ended June 30, 2024 2023 Net cash provided by operating activities $ 11,036 $ 15,533 Net cash used in investing activities (33,280 ) (11,226 ) Net cash provided by (used in) financing activities 19,228 (3,548 ) Net (decrease) increase in cash (3,016 ) 759 Cash beginning of period 6,059 2,079 Cash end of period $ 3,043 $ 2,838 THE PENNANT GROUP, INC.
REVENUE BY SEGMENT
(unaudited, dollars in thousands)The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated: Three Months Ended June 30, 2024 2023 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage Home health and hospice services Home health $ 61,637 36.5 % $ 42,411 32.1 % Hospice 59,347 35.2 46,562 35.2 Home care and other(a) 4,317 2.6 6,047 4.6 Total home health and hospice services 125,301 74.3 95,020 71.9 Senior living services 43,444 25.7 37,261 28.1 Total revenue $ 168,745 100.0 % $ 132,281 100.0 % (a) Home care and other revenue is included with home health revenue in other disclosures in this press release. Six Months Ended June 30, 2024 2023 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage Home health and hospice services Home health $ 118,849 36.5 % $ 84,191 32.5 % Hospice 113,954 35.0 89,851 34.7 Home care and other(a) 8,988 2.7 12,057 4.7 Total home health and hospice services 241,791 74.2 186,099 71.9 Senior living services 83,869 25.8 72,646 28.1 Total revenue $ 325,660 100.0 % $ 258,745 100.0 % (a) Home care and other revenue is included with home health revenue in other disclosures in this press release. THE PENNANT GROUP, INC.
SELECT PERFORMANCE INDICATORS
(unaudited, total revenue dollars in thousands)The following table summarizes our overall home health and hospice performance indicators for the each of the dates or periods indicated: Three Months Ended June 30, 2024 2023 Change % Change Total agency results: Home health and hospice revenue $ 125,301 $ 95,020 30,281 31.9 % Home health services: Total home health admissions 14,140 10,441 3,699 35.4 % Total Medicare home health admissions 5,738 4,849 889 18.3 % Average Medicare revenue per 60-day completed episode(a) $ 3,752 $ 3,519 $ 233 6.6 % Hospice services: Total hospice admissions 3,051 2,322 729 31.4 % Average daily census 3,220 2,494 726 29.1 % Hospice Medicare revenue per day $ 184 $ 189 $ (5 ) (2.6 )% Three Months Ended June 30, 2024 2023 Change % Change Same agency(b) results: Home health and hospice revenue $ 108,516 $ 94,417 $ 14,099 14.9 % Home health services: Total home health admissions 12,227 10,306 1,921 18.6 % Total Medicare home health admissions 5,074 4,785 289 6.0 % Average Medicare revenue per 60-day completed episode(a) $ 3,623 $ 3,520 $ 103 2.9 % Hospice services: Total hospice admissions 2,654 2,302 352 15.3 % Average daily census 2,864 2,494 370 14.8 % Hospice Medicare revenue per day $ 189 $ 189 $ — — % Six Months Ended June 30, 2024 2023 Change % Change Total agency results: Home health and hospice revenue $ 241,791 $ 186,099 $ 55,692 29.9 % Home health services: Total home health admissions 28,789 21,351 7,438 34.8 % Total Medicare home health admissions 12,084 9,797 2,287 23.3 % Average Medicare revenue per 60-day completed episode(a) $ 3,624 $ 3,467 $ 157 4.5 % Hospice services: Total hospice admissions 6,131 4,773 1,358 28.5 % Average daily census 3,091 2,467 624 25.3 % Hospice Medicare revenue per day $ 185 $ 186 $ (1 ) (0.5) % Six Months Ended June 30, 2024 2023 Change % Change Same agency(b) results: Home health and hospice revenue $ 212,193 $ 185,496 $ 26,697 14.4 % Home health services: Total home health admissions 24,402 21,140 3,262 15.4 % Total Medicare home health admissions 10,433 9,700 733 7.6 % Average Medicare revenue per 60-day completed episode(a) $ 3,557 $ 3,468 $ 89 2.6 % Hospice services: Total hospice admissions 5,346 4,753 593 12.5 % Average daily census 2,782 2,467 315 12.8 % Hospice Medicare revenue per day $ 188 $ 186 $ 2 1.1 % (a) The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods. (b) Same agency results represent all agencies purchased or licensed prior to January 1, 2023. The following table summarizes our senior living performance indicators for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Total senior living results: Senior living revenue $ 43,444 $ 37,261 $ 83,869 $ 72,646 Occupancy 78.8 % 78.0 % 78.7 % 78.1 % Average monthly revenue per occupied unit $ 4,790 $ 4,412 $ 4,730 $ 4,357 Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Same store senior living(a) results: Senior living revenue $ 39,691 $ 36,785 $ 78,595 $ 72,099 Occupancy 79.2 % 79.6 % 79.5 % 79.3 % Average monthly revenue per occupied unit $ 4,753 $ 4,390 $ 4,698 $ 4,342 (a) Same store senior living results is defined as all senior living communities excluding affiliate memory care units in transition, and new senior living operations acquired in 2023 or 2024. THE PENNANT GROUP, INC.
REVENUE BY PAYOR SOURCE
(unaudited, dollars in thousands)The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated: Three Months Ended June 30, 2024 2023 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage Revenue: Medicare $ 81,880 48.5 % $ 64,214 48.5 % Medicaid 26,462 15.7 18,931 14.3 Subtotal 108,342 64.2 83,145 62.8 Managed Care 21,349 12.7 17,254 13.1 Private and Other(a) 39,054 23.1 31,882 24.1 Total revenue $ 168,745 100.0 % $ 132,281 100.0 % (a) Private and other payors includes revenue from all payors generated in the Company’s home care operations and management services agreement. Six Months Ended June 30, 2024 2023 Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage Revenue: Medicare $ 158,861 48.8 % $ 124,970 48.3 % Medicaid 51,528 15.8 36,562 14.1 Subtotal 210,389 64.6 161,532 62.4 Managed Care 41,471 12.7 34,380 13.3 Private and Other(a) 73,800 22.7 62,833 24.3 Total revenue $ 325,660 100.0 % $ 258,745 100.0 % (a) Private and other payors includes revenue from all payors generated in the Company’s home care operations and management services agreement. THE PENNANT GROUP, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(unaudited, in thousands, except per share data)The following table reconciles net income to Non-GAAP net income for the periods presented: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net income attributable to The Pennant Group, Inc. $ 5,690 $ 2,797 $ 10,596 $ 4,647 Non-GAAP adjustments Costs at start-up operations(a) 98 471 178 1,001 Share-based compensation expense(b) 1,949 1,354 3,475 2,773 Acquisition related costs and credit allowances(c) 365 72 502 104 Costs associated with transitioning operations(d) 87 570 (486 ) 669 Unusual, non-recurring or redundant charges(e) 32 226 307 624 Provision for income taxes on Non-GAAP adjustments(f) (878 ) (49 ) (1,267 ) (531 ) Non-GAAP net income $ 7,343 $ 5,441 $ 13,305 $ 9,287 Dilutive Earnings Per Share As Reported Net Income $ 0.18 $ 0.09 $ 0.35 $ 0.15 Average number of shares outstanding 30,781 30,193 30,583 30,171 Adjusted Diluted Earnings Per Share Net Income $ 0.24 $ 0.18 $ 0.44 $ 0.31 Average number of shares outstanding 30,781 30,193 30,583 30,171 (a) Represents results related to start-up operations. Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenue $ (2,546 ) $ (3,286 ) $ (4,956 ) $ (5,893 ) Cost of services 2,491 3,351 4,819 6,161 Rent 150 401 306 723 Depreciation & amortization 3 5 9 10 Total Non-GAAP adjustment $ 98 $ 471 $ 178 $ 1,001 (b) Represents share-based compensation expense incurred for the periods presented. Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Cost of services $ 983 $ 781 $ 1,745 $ 1,469 General and administrative 966 573 1,730 1,304 Total Non-GAAP adjustment $ 1,949 $ 1,354 $ 3,475 $ 2,773 (c) Represents costs incurred to acquire an operation that are not capitalizable. (d) During the three months ended March 31, 2023, an affiliate of the Company placed its memory care units into transition and began seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign. Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Revenue $ (1 ) $ — $ (1 ) $ — Cost of services 34 538 (594 ) 585 Rent 52 27 104 79 Depreciation 2 5 5 5 Total Non-GAAP adjustment $ 87 $ 570 $ (486 ) $ 669 (e) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. (f) Represents an adjustment to the provision for income tax to the year-to-date effective tax rate of 26.0% and 26.0% for the six months ended June 30, 2024 and 2023, respectively. This rate excludes the tax benefit of share-based payment awards. The table below reconciles Consolidated net income to the Consolidated Non-GAAP financial measures, Consolidated Adjusted EBITDA, and to the Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the periods presented:
Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Consolidated net income $ 6,094 $ 2,922 $ 11,152 $ 4,919 Less: Net income attributable to noncontrolling interest 404 125 556 272 Add: Provision for income taxes 1,844 1,921 3,603 2,828 Net interest expense 1,622 1,453 3,414 2,859 Depreciation and amortization 1,468 1,214 2,799 2,494 Consolidated EBITDA 10,624 7,385 20,412 12,828 Adjustments to Consolidated EBITDA Add: Costs at start-up operations(a) (55 ) 65 (137 ) 268 Share-based compensation expense(b) 1,949 1,354 3,475 2,773 Acquisition related costs and credit allowances(c) 365 72 502 104 Costs associated with transitioning operations(d) 33 538 (595 ) 585 Unusual, non-recurring or redundant charges(e) 32 226 307 624 Rent related to items (a) and (d) above 202 428 410 802 Consolidated Adjusted EBITDA 13,150 10,068 24,374 17,984 Rent—cost of services 10,524 9,836 20,908 19,433 Rent related to items (a) and (d) above (202 ) (428 ) (410 ) (802 ) Adjusted rent—cost of services 10,322 9,408 20,498 18,631 Consolidated Adjusted EBITDAR(f) $ 23,472 $ 44,872 (a) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations. (b) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (c) Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations. (d) During the three months ended March 31, 2023, an affiliate of the Company placed its memory care units into transition and began seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign. (e) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. (f) This measure is a valuation measure and is displayed thusly, it is not a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated Adjusted EBITDAR should not be construed as a financial performance measure. The following table present certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments and are included in “All Other”:
Home Health and Hospice Services Senior Living Services All Other Total Segment GAAP Financial Measures: Three Months Ended June 30, 2024 Revenue $ 125,301 $ 43,444 $ — $ 168,745 Segment Adjusted EBITDAR from Operations $ 21,214 $ 12,804 $ (10,546 ) $ 23,472 Three Months Ended June 30, 2023 Revenue $ 95,020 $ 37,261 $ — $ 132,281 Segment Adjusted EBITDAR from Operations $ 15,681 $ 11,680 $ (7,885 ) $ 19,476 Home Health and Hospice Services Senior Living Services All Other Total Segment GAAP Financial Measures: Six Months Ended June 30, 2024 Revenue $ 241,791 $ 83,869 $ — $ 325,660 Segment Adjusted EBITDAR from Operations $ 40,764 $ 24,815 $ (20,707 ) $ 44,872 Six Months Ended June 30, 2023 Revenue $ 186,099 $ 72,646 $ — $ 258,745 Segment Adjusted EBITDAR from Operations $ 30,093 $ 21,921 $ (15,399 ) $ 36,615 The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to Condensed Consolidated Income from Operations:
Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Segment Adjusted EBITDAR from Operations(a) $ 23,472 $ 19,476 $ 44,872 $ 36,615 Less: Depreciation and amortization 1,468 1,214 2,799 2,494 Rent—cost of services 10,524 9,836 20,908 19,433 Other income (2 ) 35 83 65 Adjustments to Segment EBITDAR from Operations: Less: Costs at start-up operations(b) (55 ) 65 (137 ) 268 Share-based compensation expense(c) 1,949 1,354 3,475 2,773 Acquisition related costs and credit allowances(d) 365 72 502 104 Costs associated with transitioning operations(e) 33 538 (595 ) 585 Unusual, non-recurring or redundant charges(f) 32 226 307 624 Add: Net income attributable to noncontrolling interest 404 125 556 272 Consolidated Income from Operations $ 9,562 $ 6,261 $ 18,086 $ 10,541 (a) Segment Adjusted EBITDAR from Operations is net income (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs and credit allowances, (4) the costs associated with transitioning operations, (5) unusual, non-recurring or redundant charges, and (6) net income attributable to noncontrolling interest. General and administrative expenses are not allocated to the reportable segments, and are included as “All Other,” accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited. (b) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations. (c) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense. (d) Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations. (e) During the three months ended March 31, 2023, an affiliate of the Company placed its memory care units into transition and began seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with one of the entities transitioned to Ensign. (f) Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses. The tables below reconcile Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for each reportable segment for the periods presented:
Three Months Ended June 30, Home Health and Hospice Senior Living 2024 2023 2024 2023 Segment Adjusted EBITDAR from Operations $ 21,214 $ 15,681 $ 12,804 $ 11,680 Less: Rent—cost of services 1,664 1,374 8,860 8,462 Rent related to start-up and transitioning operations (57 ) (83 ) (145 ) (345 ) Segment Adjusted EBITDA from Operations $ 19,607 $ 14,390 $ 4,089 $ 3,563 Six Months Ended June 30, Home Health and Hospice Senior Living 2024 2023 2024 2023 Segment Adjusted EBITDAR from Operations $ 40,764 $ 30,093 $ 24,815 $ 21,921 Less: Rent—cost of services 3,393 2,697 17,515 16,736 Rent related to start-up and transitioning operations (122 ) (176 ) (288 ) (626 ) Segment Adjusted EBITDA from Operations $ 37,493 $ 27,572 $ 7,588 $ 5,811 Discussion of Non-GAAP Financial Measures
EBITDA consists of net income before (a) interest expense, net, (b) (benefits) provisions for income taxes, and (c) depreciation and amortization. Adjusted EBITDA consists of net income attributable to the Company before (a) interest expense, net (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) costs incurred for start-up operations, including rent and excluding depreciation, interest and income taxes, (e) share-based compensation expense, (f) non-capitalizable acquisition related costs and credit allowances, (g) net costs associated with transitioning operations, (h) unusual, non-recurring or redundant charges and (i) net income attributable to noncontrolling interest. Consolidated Adjusted EBITDAR is a valuation measure applicable to current periods only and consists of net income attributable to the Company before (a) interest expense, net, (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) costs incurred for start-up operations, excluding rent, depreciation, interest and income taxes, (f) share-based compensation expense, (g) acquisition related costs and credit allowances, (h) redundant or non-recurring transition services costs, (i) costs associated with transitioning operations, (j) unusual, non-recurring or redundant charges and (j) net income attributable to noncontrolling interest. The company believes that the presentation of EBITDA, adjusted EBITDA, consolidated adjusted EBITDAR, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. The company believes disclosure of adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA and consolidated adjusted EBITDAR has economic substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Pennant’s website at http://www.pennantgroup.com.